Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Duolac
- Development stage
- Unknown
- Lead developer
- Cell Biotech
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Duolac is a multi-strain probiotic supplement containing a combination of lactic acid bacteria (LAB), including *Streptococcus thermophilus*, *Lactobacillus acidophilus*, *Bifidobacterium lactis*, *Lactobacillus rhamnosus*, *Bifidobacterium longum*, and *Bifidobacterium bifidum*. It utilizes a patented dual-coating technology designed to protect the bacteria from gastric acid, bile salts, heat, and moisture, ensuring high survival rates and effective colonization in the intestine. Developed and investigated by Kosin University Gospel Hospital and manufactured by Cell Biotech, Duolac has been studied in clinical trials for its ability to restore gut microbiota and alleviate abdominal symptoms following colonoscopy bowel preparation, as well as for managing conditions like inflammatory bowel disease (IBD) and maintaining general gastrointestinal health.
- Brand names
- Duolac
Beyond the preview
Go deeper on Duolac.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Duolac.